MC3165 and MC3181, two nitrobenzoxadiazole (NBD) analogs that are orally active and water-soluble, specifically target GSTP1 and can inhibit viability in a panel of human melanoma cell lines and in several human melanoma xenograft models [207]. This evidence concerns the gene GSTP1 and melanoma.